Boston Scientific shares fell 2% after the company said the cyber attack would affect its net sales growth and adjusted earnings per share guidance for the third quarter and fiscal year 2026.

Boston Scientific shares fell 2% after the company said the cyber attack would affect its net sales growth and adjusted earnings per share guidance for the third quarter and fiscal year 2026.